THE CLINICAL SIGNIFICANCE OF BISULFITE BINDING SUBSTANCES (B.B.S.) IN THE BLOOD AND CEREBROSPINAL FLUID
The levels of bisulfite binding substances (B.B.S.) in the blood and cerebrospinal fluid were studied in 222 patients with neuropsychiatric and medical disorders and the following conclusions reached: 1. The usual range of B.B.S. in the spinal fluid is 1.00-2.25 mgms. per cent, which is usually 35-6...
Gespeichert in:
| Veröffentlicht in: | The American journal of psychiatry 1940-11, Vol.97 (3), p.573-588 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 588 |
|---|---|
| container_issue | 3 |
| container_start_page | 573 |
| container_title | The American journal of psychiatry |
| container_volume | 97 |
| creator | WORTIS, HERMAN BUEDING, ERNEST WILSON, WILLIAM E |
| description | The levels of bisulfite binding substances (B.B.S.) in the blood and cerebrospinal fluid were studied in 222 patients with neuropsychiatric and medical disorders and the following conclusions reached:
1. The usual range of B.B.S. in the spinal fluid is 1.00-2.25 mgms. per cent, which is usually 35-60 per cent of the amount found in an equivalent blood sample.
2. The B.B.S. may or may not be elevated in cases of clinical vitamin B1 deficiency (peripheral neuropathy, beri-beri-possibly Korsakoff and Wernicke's syndromes) but this is also true for conditions in which there is no clinical evidence of vitamin B1 deficiency. Eight cases of peripheral neuropathy in alcoholics were studied. This syndrome in alcoholics is the result of vitamin B1 deficiency.14 Four cases showed an elevated B.B.S. in the blood or cerebrospinal fluid or both, and the other four had normal figures. These variations obtained in both acute and chronic cases. Hence, the B. B. S. in the blood and cerebrospinal fluid cannot be used as an indication of vitamin B1 deficiency.
CHART XIII. BEHAVIOR AND CONDUCT DISTURBANCES(TOTAL 93 CASES). [See Figure in Source PDF]
3. A comparatively large group of psychiatric disorders, including alcoholic psychoses, schizophrenia, manic-depressive psychoses, miscellaneous psychoses and neuroses and behavior and conduct disorders in children were studied. No constant deviation from the normal was found. Uncontrolled diabetes with marked acetonuria shows a marked elevation in B.B.S.
4. Paraldehyde causes an elevation of B.B.S. in the blood for 24 hours. It is suggested that the method employed causes a partial hydrolysis of paraldehyde to acetaldehyde, which latter binds bisulfite and thereby increases the total B.B.S.
5. The B.B.S. is not an accurate indication of the pyruvic acid levels in the blood or cerebrospinal fluid. Mention is made of several cases of peripheral neuropathy in alcoholics, with elevated pyruvic acid levels in the body fluids and a normal total B.B.S. Similarly, mention is made of several cases with marked elevation of B.B.S. in the blood and cerebrospinal fluid and a normal pyruvic acid level.
6. In cases of elevated B.B.S. in the blood or cerebrospinal fluid, the factors which may contribute to that total must be individually analyzed. Pyruvic acid is only one of these factors. |
| doi_str_mv | 10.1176/ajp.97.3.573 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1310587634</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1310587634</sourcerecordid><originalsourceid>FETCH-LOGICAL-a184t-e65d65be9d15e8affbccaf2d18f12181bd1d3a89cb7bac9904401d2a9a6200dd3</originalsourceid><addsrcrecordid>eNptkE1Lw0AURQdRsFZ3_oABNxZMnI8mk1k2X-1AmEiTgLthkkmkRW1M2oX_3gl14cLVu493OA8uAPcYuRgz_1nve5czl7oeoxdghj3qOYyQ4BLMEELE4R59vQY347i3K6KMzMBbuUlglAkpolUGC7GWIrVRRgnMUxiKospSUSY2yVjINSyqsCincwEfQzd0C3cBhYSTJczyPIYrGcMo2SbhNi9ehLTSNKtEfAuuOv0-tne_cw6qNCmjjZPl6-m1o3GwPDqt7xnfq1tusNcGuuvqptEdMTjoMMEBrg02VAe8qVmtG87RcomwIZprnyBkDJ2Dh7O3Hw5fp3Y8qv3hNHzalwpTjLyA-XRpqacz1QyHcRzaTvXD7kMP3wojNVWpbJWKM0WVrdLiizOu-373R_gf-wMvKmsb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1310587634</pqid></control><display><type>article</type><title>THE CLINICAL SIGNIFICANCE OF BISULFITE BINDING SUBSTANCES (B.B.S.) IN THE BLOOD AND CEREBROSPINAL FLUID</title><source>Psychiatry Legacy Collection Online Journals 1844-1996</source><source>Periodicals Index Online</source><creator>WORTIS, HERMAN ; BUEDING, ERNEST ; WILSON, WILLIAM E</creator><creatorcontrib>WORTIS, HERMAN ; BUEDING, ERNEST ; WILSON, WILLIAM E</creatorcontrib><description>The levels of bisulfite binding substances (B.B.S.) in the blood and cerebrospinal fluid were studied in 222 patients with neuropsychiatric and medical disorders and the following conclusions reached:
1. The usual range of B.B.S. in the spinal fluid is 1.00-2.25 mgms. per cent, which is usually 35-60 per cent of the amount found in an equivalent blood sample.
2. The B.B.S. may or may not be elevated in cases of clinical vitamin B1 deficiency (peripheral neuropathy, beri-beri-possibly Korsakoff and Wernicke's syndromes) but this is also true for conditions in which there is no clinical evidence of vitamin B1 deficiency. Eight cases of peripheral neuropathy in alcoholics were studied. This syndrome in alcoholics is the result of vitamin B1 deficiency.14 Four cases showed an elevated B.B.S. in the blood or cerebrospinal fluid or both, and the other four had normal figures. These variations obtained in both acute and chronic cases. Hence, the B. B. S. in the blood and cerebrospinal fluid cannot be used as an indication of vitamin B1 deficiency.
CHART XIII. BEHAVIOR AND CONDUCT DISTURBANCES(TOTAL 93 CASES). [See Figure in Source PDF]
3. A comparatively large group of psychiatric disorders, including alcoholic psychoses, schizophrenia, manic-depressive psychoses, miscellaneous psychoses and neuroses and behavior and conduct disorders in children were studied. No constant deviation from the normal was found. Uncontrolled diabetes with marked acetonuria shows a marked elevation in B.B.S.
4. Paraldehyde causes an elevation of B.B.S. in the blood for 24 hours. It is suggested that the method employed causes a partial hydrolysis of paraldehyde to acetaldehyde, which latter binds bisulfite and thereby increases the total B.B.S.
5. The B.B.S. is not an accurate indication of the pyruvic acid levels in the blood or cerebrospinal fluid. Mention is made of several cases of peripheral neuropathy in alcoholics, with elevated pyruvic acid levels in the body fluids and a normal total B.B.S. Similarly, mention is made of several cases with marked elevation of B.B.S. in the blood and cerebrospinal fluid and a normal pyruvic acid level.
6. In cases of elevated B.B.S. in the blood or cerebrospinal fluid, the factors which may contribute to that total must be individually analyzed. Pyruvic acid is only one of these factors.</description><identifier>ISSN: 0002-953X</identifier><identifier>EISSN: 1535-7228</identifier><identifier>DOI: 10.1176/ajp.97.3.573</identifier><language>eng</language><publisher>Washington, D.C: American Psychiatric Publishing</publisher><ispartof>The American journal of psychiatry, 1940-11, Vol.97 (3), p.573-588</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a184t-e65d65be9d15e8affbccaf2d18f12181bd1d3a89cb7bac9904401d2a9a6200dd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://psychiatryonline.org/doi/epdf/10.1176/ajp.97.3.573$$EPDF$$P50$$Gappi$$H</linktopdf><linktohtml>$$Uhttps://psychiatryonline.org/doi/full/10.1176/ajp.97.3.573$$EHTML$$P50$$Gappi$$H</linktohtml><link.rule.ids>314,776,780,2845,21609,27847,27902,27903,77536,77537</link.rule.ids></links><search><creatorcontrib>WORTIS, HERMAN</creatorcontrib><creatorcontrib>BUEDING, ERNEST</creatorcontrib><creatorcontrib>WILSON, WILLIAM E</creatorcontrib><title>THE CLINICAL SIGNIFICANCE OF BISULFITE BINDING SUBSTANCES (B.B.S.) IN THE BLOOD AND CEREBROSPINAL FLUID</title><title>The American journal of psychiatry</title><description>The levels of bisulfite binding substances (B.B.S.) in the blood and cerebrospinal fluid were studied in 222 patients with neuropsychiatric and medical disorders and the following conclusions reached:
1. The usual range of B.B.S. in the spinal fluid is 1.00-2.25 mgms. per cent, which is usually 35-60 per cent of the amount found in an equivalent blood sample.
2. The B.B.S. may or may not be elevated in cases of clinical vitamin B1 deficiency (peripheral neuropathy, beri-beri-possibly Korsakoff and Wernicke's syndromes) but this is also true for conditions in which there is no clinical evidence of vitamin B1 deficiency. Eight cases of peripheral neuropathy in alcoholics were studied. This syndrome in alcoholics is the result of vitamin B1 deficiency.14 Four cases showed an elevated B.B.S. in the blood or cerebrospinal fluid or both, and the other four had normal figures. These variations obtained in both acute and chronic cases. Hence, the B. B. S. in the blood and cerebrospinal fluid cannot be used as an indication of vitamin B1 deficiency.
CHART XIII. BEHAVIOR AND CONDUCT DISTURBANCES(TOTAL 93 CASES). [See Figure in Source PDF]
3. A comparatively large group of psychiatric disorders, including alcoholic psychoses, schizophrenia, manic-depressive psychoses, miscellaneous psychoses and neuroses and behavior and conduct disorders in children were studied. No constant deviation from the normal was found. Uncontrolled diabetes with marked acetonuria shows a marked elevation in B.B.S.
4. Paraldehyde causes an elevation of B.B.S. in the blood for 24 hours. It is suggested that the method employed causes a partial hydrolysis of paraldehyde to acetaldehyde, which latter binds bisulfite and thereby increases the total B.B.S.
5. The B.B.S. is not an accurate indication of the pyruvic acid levels in the blood or cerebrospinal fluid. Mention is made of several cases of peripheral neuropathy in alcoholics, with elevated pyruvic acid levels in the body fluids and a normal total B.B.S. Similarly, mention is made of several cases with marked elevation of B.B.S. in the blood and cerebrospinal fluid and a normal pyruvic acid level.
6. In cases of elevated B.B.S. in the blood or cerebrospinal fluid, the factors which may contribute to that total must be individually analyzed. Pyruvic acid is only one of these factors.</description><issn>0002-953X</issn><issn>1535-7228</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1940</creationdate><recordtype>article</recordtype><sourceid>K30</sourceid><recordid>eNptkE1Lw0AURQdRsFZ3_oABNxZMnI8mk1k2X-1AmEiTgLthkkmkRW1M2oX_3gl14cLVu493OA8uAPcYuRgz_1nve5czl7oeoxdghj3qOYyQ4BLMEELE4R59vQY347i3K6KMzMBbuUlglAkpolUGC7GWIrVRRgnMUxiKospSUSY2yVjINSyqsCincwEfQzd0C3cBhYSTJczyPIYrGcMo2SbhNi9ehLTSNKtEfAuuOv0-tne_cw6qNCmjjZPl6-m1o3GwPDqt7xnfq1tusNcGuuvqptEdMTjoMMEBrg02VAe8qVmtG87RcomwIZprnyBkDJ2Dh7O3Hw5fp3Y8qv3hNHzalwpTjLyA-XRpqacz1QyHcRzaTvXD7kMP3wojNVWpbJWKM0WVrdLiizOu-373R_gf-wMvKmsb</recordid><startdate>194011</startdate><enddate>194011</enddate><creator>WORTIS, HERMAN</creator><creator>BUEDING, ERNEST</creator><creator>WILSON, WILLIAM E</creator><general>American Psychiatric Publishing</general><general>American Psychiatric Association</general><scope>AAYXX</scope><scope>CITATION</scope><scope>HAWNG</scope><scope>HBMBR</scope><scope>IBDFT</scope><scope>K30</scope><scope>PAAUG</scope><scope>PAWHS</scope><scope>PAWZZ</scope><scope>PAXOH</scope><scope>PBHAV</scope><scope>PBQSW</scope><scope>PBYQZ</scope><scope>PCIWU</scope><scope>PCMID</scope><scope>PCZJX</scope><scope>PDGRG</scope><scope>PDWWI</scope><scope>PETMR</scope><scope>PFVGT</scope><scope>PGXDX</scope><scope>PIHIL</scope><scope>PISVA</scope><scope>PJCTQ</scope><scope>PJTMS</scope><scope>PLCHJ</scope><scope>PMHAD</scope><scope>PNQDJ</scope><scope>POUND</scope><scope>PPLAD</scope><scope>PQAPC</scope><scope>PQCAN</scope><scope>PQCMW</scope><scope>PQEME</scope><scope>PQHKH</scope><scope>PQMID</scope><scope>PQNCT</scope><scope>PQNET</scope><scope>PQSCT</scope><scope>PQSET</scope><scope>PSVJG</scope><scope>PVMQY</scope><scope>PZGFC</scope></search><sort><creationdate>194011</creationdate><title>THE CLINICAL SIGNIFICANCE OF BISULFITE BINDING SUBSTANCES (B.B.S.) IN THE BLOOD AND CEREBROSPINAL FLUID</title><author>WORTIS, HERMAN ; BUEDING, ERNEST ; WILSON, WILLIAM E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a184t-e65d65be9d15e8affbccaf2d18f12181bd1d3a89cb7bac9904401d2a9a6200dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1940</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WORTIS, HERMAN</creatorcontrib><creatorcontrib>BUEDING, ERNEST</creatorcontrib><creatorcontrib>WILSON, WILLIAM E</creatorcontrib><collection>CrossRef</collection><collection>Periodicals Index Online Segment 13</collection><collection>Periodicals Index Online Segment 14</collection><collection>Periodicals Index Online Segment 27</collection><collection>Periodicals Index Online</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - West</collection><collection>Primary Sources Access (Plan D) - International</collection><collection>Primary Sources Access & Build (Plan A) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Midwest</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Northeast</collection><collection>Primary Sources Access (Plan D) - Southeast</collection><collection>Primary Sources Access (Plan D) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Southeast</collection><collection>Primary Sources Access (Plan D) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - UK / I</collection><collection>Primary Sources Access (Plan D) - Canada</collection><collection>Primary Sources Access (Plan D) - EMEALA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - North Central</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - International</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - International</collection><collection>Primary Sources Access (Plan D) - West</collection><collection>Periodicals Index Online Segments 1-50</collection><collection>Primary Sources Access (Plan D) - APAC</collection><collection>Primary Sources Access (Plan D) - Midwest</collection><collection>Primary Sources Access (Plan D) - MEA</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - Canada</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - EMEALA</collection><collection>Primary Sources Access & Build (Plan A) - APAC</collection><collection>Primary Sources Access & Build (Plan A) - Canada</collection><collection>Primary Sources Access & Build (Plan A) - West</collection><collection>Primary Sources Access & Build (Plan A) - EMEALA</collection><collection>Primary Sources Access (Plan D) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - Midwest</collection><collection>Primary Sources Access & Build (Plan A) - North Central</collection><collection>Primary Sources Access & Build (Plan A) - Northeast</collection><collection>Primary Sources Access & Build (Plan A) - South Central</collection><collection>Primary Sources Access & Build (Plan A) - Southeast</collection><collection>Primary Sources Access (Plan D) - UK / I</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - APAC</collection><collection>Primary Sources Access—Foundation Edition (Plan E) - MEA</collection><jtitle>The American journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WORTIS, HERMAN</au><au>BUEDING, ERNEST</au><au>WILSON, WILLIAM E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>THE CLINICAL SIGNIFICANCE OF BISULFITE BINDING SUBSTANCES (B.B.S.) IN THE BLOOD AND CEREBROSPINAL FLUID</atitle><jtitle>The American journal of psychiatry</jtitle><date>1940-11</date><risdate>1940</risdate><volume>97</volume><issue>3</issue><spage>573</spage><epage>588</epage><pages>573-588</pages><issn>0002-953X</issn><eissn>1535-7228</eissn><abstract>The levels of bisulfite binding substances (B.B.S.) in the blood and cerebrospinal fluid were studied in 222 patients with neuropsychiatric and medical disorders and the following conclusions reached:
1. The usual range of B.B.S. in the spinal fluid is 1.00-2.25 mgms. per cent, which is usually 35-60 per cent of the amount found in an equivalent blood sample.
2. The B.B.S. may or may not be elevated in cases of clinical vitamin B1 deficiency (peripheral neuropathy, beri-beri-possibly Korsakoff and Wernicke's syndromes) but this is also true for conditions in which there is no clinical evidence of vitamin B1 deficiency. Eight cases of peripheral neuropathy in alcoholics were studied. This syndrome in alcoholics is the result of vitamin B1 deficiency.14 Four cases showed an elevated B.B.S. in the blood or cerebrospinal fluid or both, and the other four had normal figures. These variations obtained in both acute and chronic cases. Hence, the B. B. S. in the blood and cerebrospinal fluid cannot be used as an indication of vitamin B1 deficiency.
CHART XIII. BEHAVIOR AND CONDUCT DISTURBANCES(TOTAL 93 CASES). [See Figure in Source PDF]
3. A comparatively large group of psychiatric disorders, including alcoholic psychoses, schizophrenia, manic-depressive psychoses, miscellaneous psychoses and neuroses and behavior and conduct disorders in children were studied. No constant deviation from the normal was found. Uncontrolled diabetes with marked acetonuria shows a marked elevation in B.B.S.
4. Paraldehyde causes an elevation of B.B.S. in the blood for 24 hours. It is suggested that the method employed causes a partial hydrolysis of paraldehyde to acetaldehyde, which latter binds bisulfite and thereby increases the total B.B.S.
5. The B.B.S. is not an accurate indication of the pyruvic acid levels in the blood or cerebrospinal fluid. Mention is made of several cases of peripheral neuropathy in alcoholics, with elevated pyruvic acid levels in the body fluids and a normal total B.B.S. Similarly, mention is made of several cases with marked elevation of B.B.S. in the blood and cerebrospinal fluid and a normal pyruvic acid level.
6. In cases of elevated B.B.S. in the blood or cerebrospinal fluid, the factors which may contribute to that total must be individually analyzed. Pyruvic acid is only one of these factors.</abstract><cop>Washington, D.C</cop><pub>American Psychiatric Publishing</pub><doi>10.1176/ajp.97.3.573</doi><tpages>16</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-953X |
| ispartof | The American journal of psychiatry, 1940-11, Vol.97 (3), p.573-588 |
| issn | 0002-953X 1535-7228 |
| language | eng |
| recordid | cdi_proquest_journals_1310587634 |
| source | Psychiatry Legacy Collection Online Journals 1844-1996; Periodicals Index Online |
| title | THE CLINICAL SIGNIFICANCE OF BISULFITE BINDING SUBSTANCES (B.B.S.) IN THE BLOOD AND CEREBROSPINAL FLUID |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T09%3A20%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=THE%20CLINICAL%20SIGNIFICANCE%20OF%20BISULFITE%20BINDING%20SUBSTANCES%20(B.B.S.)%20IN%20THE%20BLOOD%20AND%20CEREBROSPINAL%20FLUID&rft.jtitle=The%20American%20journal%20of%20psychiatry&rft.au=WORTIS,%20HERMAN&rft.date=1940-11&rft.volume=97&rft.issue=3&rft.spage=573&rft.epage=588&rft.pages=573-588&rft.issn=0002-953X&rft.eissn=1535-7228&rft_id=info:doi/10.1176/ajp.97.3.573&rft_dat=%3Cproquest_cross%3E1310587634%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1310587634&rft_id=info:pmid/&rfr_iscdi=true |